VSee Health Announces Filing Second Quarter 2025 Results

SAN JOSE, CA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, reported its financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024").

Highlights

• Second Quarter 2025 revenue of $3.4 million, up 98% year-over-year

• Second Quarter 2025 Gross profit margin increased from 45% to 47%

Liquidity and Cash Flow

Cash flow used in operations was $765,094 in the first six months of 2025, compared to $2,594,214 in the first six months of 2024. Cash flow used in investing activities was $15,466 for the first six months of 2025, compared to $16,390 in the first six months of 2024. Cash flow from financing activities was $746,040 in the first six months of 2025, compared to $3,597,841 in the first six months of 2024.

The integration of iDoc Telehealth has been challenging yet the rewards of robust revenue growth, expanded customer relationships and operational progress should provide comfort to shareholders and interested parties alike that the Company is on the right path. The Company's is experiencing more than 100% year-over-year revenue growth which has been largely driven by the acquisition of iDoc and the growth of the Company's telehealth service. With the consolidation of VSee Lab and iDoc platforms, aligning physician coverage, service offerings, and client delivery models the Company believes both revenue growth and operational efficiencies will deliver monumental operational improvements for the near future. Finally, new clients have provided strong revenue growth and expansion into new services has improved gross margins, management is not yet satisfied and is committed to build shareholder value.

"We are extremely proud of our team's execution during the exhausting acquisition process. Our growing revenue and improved operational efficiencies have laid the foundation for continued success, but we also understand that much work needs to be done to improve shareholder value. As we enter this next phase of growth, we are committed to providing products and services that will be in high demand, improve patient care, and bring efficiencies to service providers. We understand if we continue to improve our offerings the natural end result will be improved shareholder value. Although we are pleased with the results from the financial results reported in the 10Q for the period ended 06/30/2025, we also understand we have a tremendous amount of work ahead of us. We promise to deliver results our customers and shareholders will be proud of. We commit to work relentlessly until every aspect of our business and operations are out preforming expectations," said Dr. Milton Chen, and Dr. Imo Aisiku, Co-Chief Executive Officer of VSee Health.